๐ฐ Genevant Sciences News
Page 2 - Genevant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genevant Sciences. Real-time updates on events, politics, business and more.
December 21, 2023
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
November 6, 2023
VANCOUVER, British Columbia, and BASEL, Switzerland, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and an expansive lipid nanoparticle (LNP)
October 12, 2023
/PRNewswire/ -- The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key...
October 12, 2023
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The
October 12, 2023
VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle
October 5, 2023
Biora Therapeutics (NASDAQ:BIOR – Get Free Report) and Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of current […]
October 5, 2023
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin
September 28, 2023
Twenty-five intellectual property luminaries sent a letter today to several members of Congress asking them to beware of misleading and inaccurate assertions by โactivists and academicsโ that government price controls on drugs will lead to lower costs for consumers.
September 4, 2023
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
August 21, 2023
Precision BioSciences (NASDAQ:DTIL – Get Free Report) and Gritstone bio (NASDAQ:GRTS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Risk and Volatility Precision BioSciences has a […]